Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unhappy While Depressed: Examining the Dimensionality, Reliability and Validity of the Subjective Happiness Scale in a Spanish Sample of Patients with Depressive Disorders.
Feliu-Soler A, de Diego-Adeliño J, Luciano JV, Iraurgi I, Alemany C, Puigdemont D, Pérez V, Portella MJ, Trujols J. Feliu-Soler A, et al. Among authors: alemany c. Int J Environ Res Public Health. 2021 Oct 19;18(20):10964. doi: 10.3390/ijerph182010964. Int J Environ Res Public Health. 2021. PMID: 34682709 Free PMC article.
Randomized clinical trial of integral cognitive remediation program for major depression (INCREM).
Vicent-Gil M, González-Simarro S, Raventós B, Vera J, Marín Martínez ED, Sabaté-Cao C, Pérez-Blanco J, Puigdemont D, de Diego-Adeliño J, Alemany C, Serra-Blasco M, Cardoner N, Portella MJ. Vicent-Gil M, et al. Among authors: alemany c. J Affect Disord. 2022 Aug 1;310:189-197. doi: 10.1016/j.jad.2022.05.016. Epub 2022 May 8. J Affect Disord. 2022. PMID: 35545155 Clinical Trial.
Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?
Portella MJ, Arteaga-Henríquez G, de Diego-Adeliño J, Trujols J, Puigdemont D, Pérez J, Alemany C, Carrasco-Hernández J, Udina M, Cardoner N, Vicent-Gil M. Portella MJ, et al. Among authors: alemany c. Gen Hosp Psychiatry. 2024 Oct 9:S0163-8343(24)00208-1. doi: 10.1016/j.genhosppsych.2024.10.003. Online ahead of print. Gen Hosp Psychiatry. 2024. PMID: 39395857 No abstract available.
Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females.
Serra-Navarro M, Amoretti S, Verdolini N, Forte MF, Sánchez-Torres AM, Vieta E, Clougher D, Lobo A, González-Pinto A, Panadero R, Roldán A, Carvalho AF, de la Serna E, Toll A, Ramos-Quiroga JA, Torrent C, Cuesta MJ, Bernardo M; PEPs Group. Serra-Navarro M, et al. Front Psychiatry. 2022 Oct 20;13:982583. doi: 10.3389/fpsyt.2022.982583. eCollection 2022. Front Psychiatry. 2022. PMID: 36339856 Free PMC article.
Practice of Electroconvulsive Therapy in Catalonia in 2022: Results From a Large Cross-Sectional Survey.
Gil-Badenes J, Alemany C, Iglesias M, de Arriba A, Foguet-Boreu Q, Hernández-Ribas R, Carrión MI, Alcoverro O, Aguilar Ortiz S, Torrent A, Bassa A, Ros L, Bergé D, Giménez-Palomo A, Urretavizcaya M, Martinez-Amoros E. Gil-Badenes J, et al. Among authors: alemany c. J ECT. 2024 Dec 3. doi: 10.1097/YCT.0000000000001091. Online ahead of print. J ECT. 2024. PMID: 39652058
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free PMC article. Clinical Trial.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG. Choueiri TK, et al. Among authors: alemany c. Lancet Oncol. 2023 Mar;24(3):228-238. doi: 10.1016/S1470-2045(23)00049-9. Lancet Oncol. 2023. PMID: 36858721 Clinical Trial.
52 results